Assignee
ABELZETA INC
US8 patents
Top patents by PatentIndex Score
US12448432B2Oct 21, 2025
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
ABELZETA INC1 citations73
US12311022B2May 27, 2025
Bispecific chimeric antigen receptors targeting CD20 and BCMA
ABELZETA INC2 citations73
US12458667B2Nov 4, 2025
Bispecific chimeric antigen receptors targeting CD20 and BCMA
ABELZETA INC1 citations63
US12583903B2Mar 24, 2026
Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
ABELZETA INC0 citations61
US12577541B2Mar 17, 2026
Method for large-scale preparation of purified preparation of recombinant lentiviral vector at GMP grade
ABELZETA INC0 citations59
US12338494B2Jun 24, 2025
Reagent and method for fluorescence quantitative real-time PCR detection of RCL
ABELZETA INC0 citations59
US12018293B2Jun 25, 2024
Method for large-scale preparation of purified preparation of recombinant lentiviral vector at GMP grade
ABELZETA INC0 citations59
US12356981B2Jul 15, 2025
Cell freezing medium for clinical use
ABELZETA INC0 citations58